MDXH
Price
$3.53
Change
-$0.00 (-0.00%)
Updated
Sep 5, 01:27 PM (EDT)
Capitalization
174.73M
68 days until earnings call
SAFLF
Price
$1.60
Change
+$0.10 (+6.67%)
Updated
Sep 2 closing price
Capitalization
710.16M
Interact to see
Advertisement

MDXH vs SAFLF

Header iconMDXH vs SAFLF Comparison
Open Charts MDXH vs SAFLFBanner chart's image
MDxHealth SA
Price$3.53
Change-$0.00 (-0.00%)
Volume$300
Capitalization174.73M
Safilo Group Spa
Price$1.60
Change+$0.10 (+6.67%)
Volume$100
Capitalization710.16M
MDXH vs SAFLF Comparison Chart in %
Loading...
MDXH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAFLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MDXH vs. SAFLF commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDXH is a Buy and SAFLF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2025
Stock price -- (MDXH: $3.53 vs. SAFLF: $1.60)
Brand notoriety: MDXH and SAFLF are both not notable
MDXH represents the Medical Specialties, while SAFLF is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: MDXH: 152% vs. SAFLF: 0%
Market capitalization -- MDXH: $174.73M vs. SAFLF: $710.16M
MDXH [@Medical Specialties] is valued at $174.73M. SAFLF’s [@Pharmaceuticals: Other] market capitalization is $710.16M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.93B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.57B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDXH’s FA Score shows that 0 FA rating(s) are green whileSAFLF’s FA Score has 0 green FA rating(s).

  • MDXH’s FA Score: 0 green, 5 red.
  • SAFLF’s FA Score: 0 green, 5 red.
According to our system of comparison, both MDXH and SAFLF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MDXH’s TA Score shows that 3 TA indicator(s) are bullish while SAFLF’s TA Score has 2 bullish TA indicator(s).

  • MDXH’s TA Score: 3 bullish, 4 bearish.
  • SAFLF’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, MDXH is a better buy in the short-term than SAFLF.

Price Growth

MDXH (@Medical Specialties) experienced а +2.02% price change this week, while SAFLF (@Pharmaceuticals: Other) price change was +6.67% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.45%. For the same industry, the average monthly price growth was +7.00%, and the average quarterly price growth was +11.91%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.57%. For the same industry, the average monthly price growth was +6.79%, and the average quarterly price growth was +18.37%.

Reported Earning Dates

MDXH is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Medical Specialties (+0.45% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (-1.57% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SAFLF($710M) has a higher market cap than MDXH($175M). SAFLF YTD gains are higher at: 63.215 vs. MDXH (48.945). SAFLF has higher annual earnings (EBITDA): 107M vs. MDXH (-14.22M). SAFLF has more cash in the bank: 72.6M vs. MDXH (32.8M). MDXH has less debt than SAFLF: MDXH (84M) vs SAFLF (115M). SAFLF has higher revenues than MDXH: SAFLF (999M) vs MDXH (99M).
MDXHSAFLFMDXH / SAFLF
Capitalization175M710M25%
EBITDA-14.22M107M-13%
Gain YTD48.94563.21577%
P/E RatioN/A12.28-
Revenue99M999M10%
Total Cash32.8M72.6M45%
Total Debt84M115M73%
FUNDAMENTALS RATINGS
MDXH vs SAFLF: Fundamental Ratings
MDXH
SAFLF
OUTLOOK RATING
1..100
1050
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
64
Fair valued
PROFIT vs RISK RATING
1..100
10072
SMR RATING
1..100
10070
PRICE GROWTH RATING
1..100
3636
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
1132

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MDXH's Valuation (61) in the null industry is in the same range as SAFLF (64). This means that MDXH’s stock grew similarly to SAFLF’s over the last 12 months.

SAFLF's Profit vs Risk Rating (72) in the null industry is in the same range as MDXH (100). This means that SAFLF’s stock grew similarly to MDXH’s over the last 12 months.

SAFLF's SMR Rating (70) in the null industry is in the same range as MDXH (100). This means that SAFLF’s stock grew similarly to MDXH’s over the last 12 months.

SAFLF's Price Growth Rating (36) in the null industry is in the same range as MDXH (36). This means that SAFLF’s stock grew similarly to MDXH’s over the last 12 months.

SAFLF's P/E Growth Rating (100) in the null industry is in the same range as MDXH (100). This means that SAFLF’s stock grew similarly to MDXH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MDXHSAFLF
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
45%
Bearish Trend 2 days ago
57%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
52%
Bearish Trend 2 days ago
42%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
27%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
36%
Bullish Trend 2 days ago
23%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
63%
Aroon
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
27%
View a ticker or compare two or three
Interact to see
Advertisement
MDXH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAFLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IGGGF0.57N/A
N/A
IGG, Inc.
VARGF20.20N/A
N/A
Varta AG
WBNEF0.15N/A
N/A
Westbond Enterprises Corp.
JMPLY51.47-0.25
-0.48%
Johnson Matthey plc
EPIAF20.82-0.70
-3.27%
Epiroc Aktiebolag

MDXH and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDXH has been loosely correlated with AMBBY. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if MDXH jumps, then AMBBY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDXH
1D Price
Change %
MDXH100%
-1.67%
AMBBY - MDXH
34%
Loosely correlated
-1.93%
SAFLF - MDXH
28%
Poorly correlated
N/A
CSTL - MDXH
28%
Poorly correlated
-0.47%
IRIX - MDXH
27%
Poorly correlated
-4.69%
BNGO - MDXH
26%
Poorly correlated
-6.19%
More

SAFLF and

Correlation & Price change

A.I.dvisor tells us that SAFLF and ICCM have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SAFLF and ICCM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SAFLF
1D Price
Change %
SAFLF100%
N/A
ICCM - SAFLF
28%
Poorly correlated
+0.95%
MDXH - SAFLF
28%
Poorly correlated
-1.67%
XAIR - SAFLF
25%
Poorly correlated
-6.06%
GRRMF - SAFLF
24%
Poorly correlated
N/A
AMBBY - SAFLF
24%
Poorly correlated
-1.93%
More